rss
Br J Ophthalmol 2008;92:1086-1091 doi:10.1136/bjo.2007.133231
  • Original Article
    • Clinical science

Cone and cone–rod dystrophy segregating in the same pedigree due to the same novel CRX gene mutation

  1. V B D Kitiratschky1,2,
  2. D Nagy3,
  3. T Zabel3,
  4. E Zrenner1,
  5. B Wissinger1,
  6. S Kohl1,
  7. H Jägle3
  1. 1
    Centre of Ophthalmology, Institute for Ophthalmic Research, Molecular Genetics Laboratory, Tübingen, Germany
  2. 2
    Graduate School of Neural & Behavioural Sciences, International Max Planck Research School, University Tübingen, Tübingen, Germany
  3. 3
    Centre of Ophthalmology, University Eye Hospital, Tübingen, Germany
  1. Dr H Jägle, Centre of Ophthalmology, University Eye Hospital, Schleichstr. 12–16, D-72076 Tübingen, Germany; herbert.jaegle{at}uni-tuebingen.de
  • Accepted 16 April 2008

Abstract

Aim: To describe the detailed phenotypes of a multi-generation family affected by autosomal dominant cone–rod dystrophy (adCRD) and characterised by marked intrafamilial heterogeneity, due to a novel frameshift mutation in the CRX gene.

Methods: Six affected and two unaffected family members underwent detailed ophthalmological examination as well as psychophysical and electrophysiological testing. Mutation screening of the CRX gene and segregation analysis were performed in 14 family members from three generations.

Results: Clinical examination of six available mutation carriers showed marked phenotypic heterogeneity, presenting with a reduced cone electroretinogram (ERG) and normal rod ERG in one family branch and a negative ERG in the other as the most striking feature. Genetic screening identified a novel mutation in the CRX gene, c.636delC, that independently segregates with the disease in both branches of the family.

Conclusion: The authors identified a novel disease causing mutation in the CRX gene associated with adCRD. Furthermore, we show here for the first time the coexistence of a reduced cone and a negative ERG component in different individuals of the same family, all affected by the same mutation.

Footnotes

  • Funding: German Research Council KFO134—Ko2176/1-1 and JA997/8-1 to SK and BW, and HJ and EZ, respectively, and EU programme Evi-Genoret LSHG-CT-2005-512036.

  • Competing interests: None.

  • Ethics approval: This study conformed to the tenet of the Declaration of Helsinki and received approval from the Ethical Committee of the University Tübingen.

  • Patient consent: Obtained.

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.